Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer (original) (raw)

• Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604–616
  Article PubMed CAS Google Scholar
• Saddoughi SA, Song P, Ogretmen B (2008) Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49:413–440
  Article PubMed Google Scholar
• Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Bba-Biomembranes 1758:1957–1977
  Article PubMed CAS Google Scholar
• Tettamanti G, Bassi R, Viani P, Riboni L (2003) Salvage pathways in glycosphingolipid metabolism. Biochimie 85(3–4):423–437
  Article PubMed CAS Google Scholar
• Ozbayraktar FBK, Ulgen KO (2010) Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis. J Biomed Inform 43:537–549
  Article PubMed Google Scholar
• Ekiz HA, Baran Y (2010) Therapeutic applications of bioactive sphingolipids in hematological malignancies. Int J Cancer 127:1497–1506
  Article PubMed CAS Google Scholar
• Ozbayraktar FB, Ulgen KO (2009) Molecular facets of sphingolipids: mediators of diseases. Biotechnol J 4:1028–1041
  Article PubMed CAS Google Scholar
• Tyteca D, D’Auria L, Der Smissen PV, Medts T, Carpentier S, Monbaliu JC, de Diesbach P, Courtoy PJ (2010) Three unrelated sphingomyelin analogs spontaneously cluster into plasma membrane micrometric domains. Bba-Biomembranes 1798:909–927
  Article PubMed CAS Google Scholar
• Patwardhan GA, Liu YY (2011) Sphingolipids and expression regulation of genes in cancer. Prog Lipid Res 50:104–114
  Article PubMed CAS Google Scholar
• Snook CF, Jones JA, Hannun YA (2006) Sphingolipid-binding proteins. Biochim Biophys Acta 1761:927–946
  Article PubMed CAS Google Scholar
• Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169–180
  Article PubMed CAS Google Scholar
• Sabourdy F, Kedjouar B, Sorli SC, Colie S, Milhas D, Salma Y, Levade T (2008) Functions of sphingolipid metabolism in mammals—lessons from genetic defects. Bba-Mol Cell Biol L 1781:145–183
  CAS Google Scholar
• Cuvillier O, Levade T (2003) Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancer. Pharmacol Res 47:439–445
  Article PubMed CAS Google Scholar
• Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood JC, Liu Y, Peng Q, Ramaraju H, Sullards M, Cabot M, Merrill AH (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Bba-Biomembranes 1758:1864–1884
  Article PubMed CAS Google Scholar
• Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Bio 9:139–150
  Article CAS Google Scholar
• Bartke N, Hannun YA (2009) Bioactive sphingolipids: metabolism and function. J Lipid Res 50(Suppl):S91–S96
  Article PubMed Google Scholar
• Perry RJ, Ridgway ND (2005) Molecular mechanisms and regulation of ceramide transport. Biochim Biophys Acta 1734:220–234
  Article PubMed CAS Google Scholar
• Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010–1018
  Article PubMed CAS Google Scholar
• Dyatlovitskaya EV, Kandyba AG (2006) Role of biologically active sphingolipids in tumor growth. Biochemistry (Moscow) 71:10–17
  Article CAS Google Scholar
• Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 1758:1957–1977
  Article PubMed CAS Google Scholar
• Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, Jiang JC, Jazwinski SM, Hannun YA, Ogretmen B (2007) Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 6:712–722
  Article PubMed CAS Google Scholar
• Parihar A, Parihar MS, Nazarewicz R, Ghafourifar P (2010) Importance of cytochrome c redox state for ceramide-induced apoptosis of human mammary adenocarcinoma cells. Bba Gen Subjects 1800:646–654
  Article CAS Google Scholar
• Wang J, Lv XW, Du YG (2009) Potential mechanisms involved in ceramide-induced apoptosis in human colon cancer HT29 cells. Biomed Environ Sci 22:76–85
  Article PubMed CAS Google Scholar
• Liu YY, Han TY, Yu JY, Bitterman A, Le A, Giuliano AE, Cabot MC (2004) Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells. J Lipid Res 45:933–940
  Article PubMed CAS Google Scholar
• Yoshizaki F, Nakayama H, Wahara C, Takamori K, Ogawa H, Iwabuchi K (2008) Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Bba-Gen Subjects 1780:383–392
  Article CAS Google Scholar
• Hakomori SI (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Bba-Gen Subjects 1780:325–346
  Article CAS Google Scholar
• Bleicher RJ, Cabot MC (2002) Glucosylceramide synthase and apoptosis. Bba Mol Cell Biol L 1585:172–178
  Article CAS Google Scholar
• Barreto-Bergter E, Pinto MR, Rodrigues ML (2004) Structure and biological functions of fungal cerebrosides. An Acad Bras Cienc 76:67–84
  Article PubMed CAS Google Scholar
• Maunula S, Bjorkqvist YJE, Slotte JP, Ramstedt B (2007) Differences in the domain forming properties of N-palmitoylated neutral glycosphingolipids in bilayer. Bba-Biomembranes 1768:336–345
  Article PubMed CAS Google Scholar
• Degroote S, Wolthoorn J, van Meer G (2004) The cell biology of glycosphingolipids. Semin Cell Dev Biol 15:375–387
  Article PubMed CAS Google Scholar
• Duclos RI (2001) The total syntheses of D-erythro-sphingosine, N-palmitoylsphingosine (ceramide), and glucosylceramide (cerebroside) via an azidosphingosine analog. Chem Phys Lipids 111:111–138
  Article PubMed CAS Google Scholar
• van Meer G, Holthuis JC (2000) Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta 1486:145–170
  Article PubMed Google Scholar
• Aerts JMFG, Ghisaidoobe A, Bikker P, de Bruijn ACJ, Godschalk FD, Rogaar E, Guijt MC, Hagens P, Halma JM, van’t Hart SM, Luitjens SB, van Rixel VHS, Wijzenbroek M, Zweegers T, Donker-Koopman WE, Strijland A, Boot R, van der Marel G, Overkleeft HS, van den Berg RJBHN (2011) Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars. Acs Med Chem Lett 2:119–123
  Article Google Scholar
• Tuuf J, Kjellberg MA, Molotkovsky JG, Hanada K, Mattjus P (2011) The intermembrane ceramide transport catalyzed by CERT is sensitive to the lipid environment. Biochim Biophys Acta 1808:229–235
  Article PubMed CAS Google Scholar
• Liu YY, Han TY, Giuliano AE, Cabot MC (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274:1140–1146
  Article PubMed CAS Google Scholar
• Leipelt M, Warnecke D, Zahringer U, Ott C, Muller F, Hube B, Heinz E (2001) Glucosylceramide synthases, a gene family responsible for the biosynthesis of glycosphingolipids in animals, plants, and fungi. J Biol Chem 276:33621–33629
  Article PubMed CAS Google Scholar
• Hillig I, Leipelt M, Ott C, Zahringer U, Warnecke D, Heinz E (2003) Formation of glucosylceramide and sterol glucoside by a UDP-glucose-dependent glucosylceramide synthase from cotton expressed in Pichia pastoris. FEBS Lett 553:365–369
  Article PubMed CAS Google Scholar
• Ito M, Komori H (1996) Homeostasis of cell-surface glycosphingolipid content in B16 melanoma cells. Evidence revealed by an endoglycoceramidase. J Biol Chem 271:12655–12660
  Article PubMed CAS Google Scholar
• Inokuchi J, Jimbo M, Momosaki K, Shimeno H, Nagamatsu A, Radin NS (1990) Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res 50:6731–6737
  PubMed CAS Google Scholar
• Lafont D, Bouchu MN, Girard-Egrot A, Boullanger P (2001) Syntheses and interfacial behaviour of neoglycolipid analogues of glycosyl ceramides. Carbohydr Res 336:181–194
  Article PubMed CAS Google Scholar
• Miura T, Kajimoto T, Jimbo M, Yamagishi K, Inokuchi JC, Wong CH (1998) Synthesis and evaluation of morpholino- and pyrrolidinosphingolipids as inhibitors of glucosylceramide synthase. Bioorg Med Chem 6:1481–1489
  Article PubMed CAS Google Scholar
• Chujor CS, Feingold KR, Elias PM, Holleran WM (1998) Glucosylceramide synthase activity in murine epidermis: quantitation, localization, regulation, and requirement for barrier homeostasis. J Lipid Res 39:277–285
  PubMed CAS Google Scholar
• Abe A, Radin NS, Shayman JA, Wotring LL, Zipkin RE, Sivakumar R, Ruggieri JM, Carson KG, Ganem B (1995) Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J Lipid Res 36:611–621
  PubMed CAS Google Scholar
• Hillig I, Warnecke D, Heinz E (2005) An inhibitor of glucosylceramide synthase inhibits the human enzyme, but not enzymes from other organisms. Biosci Biotechnol Biochem 69:1782–1785
  Article PubMed CAS Google Scholar
• Di Sano F, Di Bartolomeo S, Fazi B, Fiorentini C, Matarrese P, Spinedi A, Piacentini M (2002) Antisense to glucosylceramide synthase in human neuroepithelioma affects cell growth but not apoptosis. Cell Death Differ 9:693–695
  Article PubMed Google Scholar
• Ichikawa S, Hirabayashi Y (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 8:198–202
  Article PubMed CAS Google Scholar
• Xie P, Shen YF, Shi YP, Ge SM, Gu ZH, Wang J, Mu HJ, Zhang B, Qiao WZ, Xie KM (2008) Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 32:475–480
  Article PubMed CAS Google Scholar
• Compain P, Martin OR, Boucheron C, Godin G, Yu L, Ikeda K, Asano N (2006) Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher’s disease. ChemBioChem 7:1356–1359
  Article PubMed CAS Google Scholar
• Basu S, Kaufman B, Roseman S (1968) Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain. J Biol Chem 243:5802–5804
  PubMed CAS Google Scholar
• Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K (2000) Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485:63–99
  Article PubMed CAS Google Scholar
• Liu Y, Xie KM, Yang GQ, Bai XM, Shi YP, Mu HJ, Qiao WZ, Zhang B, Xie P (2010) GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line. Cancer Chemother Pharmacol 66:433–439
  Article PubMed CAS Google Scholar
• Turzanski J, Grundy M, Shang S, Russell N, Pallis M (2005) P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway. Exp Hematol 33:62–72
  Article PubMed CAS Google Scholar
• Fujikawa K, Nohara T, Imamura A,Ando H, Ishida H, Kiso M (2010) A cyclic glucosyl ceramide acceptor as a versatile building block for complex ganglioside synthesis. Tetrahedron Lett 51:1126–1130
  Google Scholar
• Gouaze V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, Gottesman MM, Bitterman A, Giuliano AE, Cabot MC (2004) Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 3:633–639
  PubMed CAS Google Scholar
• Sietsma H, Veldman RJ, Kok JW (2001) The involvement of sphingolipids in multidrug resistance. J Membr Biol 181:153–162
  PubMed CAS Google Scholar
• Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL, Cabot MC (1998) Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res 18:475–480
  PubMed CAS Google Scholar
• Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T (2003) Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. Clin Cancer Res 9:415–423
  PubMed CAS Google Scholar
• Lavie Y, Cao H, Volner A, Lucci A, Han TY, Geffen V, Giuliano AE, Cabot MC (1997) Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 272:1682–1687
  Article PubMed CAS Google Scholar
• Liu YY, Han TY, Giuliano AE, Cabot MC (2001) Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 15:719–730
  Article PubMed CAS Google Scholar
• Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271:19530–19536
  Article PubMed CAS Google Scholar
• Chapman JV, Gouaze-Andersson V, Cabot MC (2010) Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity. Int J Oncol 37:1591–1597
  PubMed CAS Google Scholar
• Gouaze-Andersson V, Yu JY, Kreitenberg AJ, Bielawska A, Giuliano AE, Cabot MC (2007) Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta 1771:1407–1417
  Article PubMed CAS Google Scholar
• Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, Holleran WM, Giuliano AE, Jazwinski SM, Gouaze-Andersson V, Consoli DP, Cabot MC (2008) A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 22:2541–2551
  Article PubMed CAS Google Scholar
• Albi MVME (2008) Sphingolipid metabolism inhibitors and cell function. Open Enzym Inhib J 1:72–79
  Article CAS Google Scholar
• van Vlerken LE, Duan Z, Seiden MV, Amiji MM (2007) Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 67:4843–4850
  Article PubMed Google Scholar
• Siddiqui A, Patwardhan GA, Liu YY, Nazzal S (2010) Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells. Int J Pharm 400:251–259
  Article PubMed CAS Google Scholar
• Patwardhan GA, Zhang QJ, Yin D, Gupta V, Bao J, Senkal CE, Ogretmen B, Cabot MC, Shah GV, Sylvester PW, Jazwinski SM, Liu YY (2009) A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis. PLoS ONE 4:e6938
  Article PubMed Google Scholar
• Sun Y, Zhang T, Gao P, Meng B, Gao Y, Wang X, Zhang J, Wang H, Wu X, Zheng W, Zhou G (2010) Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. Breast Cancer Res Treat 121:591–599
  Article PubMed CAS Google Scholar
• Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G (2009) Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther 8:1117–1121
  Article PubMed CAS Google Scholar
• Baran Y, Bielawski J, Ogretmen B, Gunduz U (2011) Inhibition of glucosylceramide synthase by PDMP resensitizes multidrug-resistant human chronic myeloid leukemia cells to Imatinib. J Can Res Clin Oncol 137(10):1535–1544
  Article CAS Google Scholar
• Kok JW, Sietsma H (2004) Sphingolipid metabolism enzymes as targets for anticancer therapy. Curr Drug Targets 5:375–382
  Article PubMed CAS Google Scholar
• Radin NS (1994) Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase. Mol Chem Neuropathol 21:111–127
  Article PubMed CAS Google Scholar
• Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP (1999) Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst 91:1138–1146
  Article PubMed CAS Google Scholar
• Radin NS (1999) Chemotherapy by slowing glycosphingolipid synthesis. Biochem Pharmacol 57:589–595
  Article PubMed CAS Google Scholar
• Weiss M, Hettmer S, Smith P, Ladisch S (2003) Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res 63:3654–3658
  PubMed CAS Google Scholar
• Di Sano F, Fazi B, Citro G, Lovat PE, Cesareni G, Piacentini M (2003) Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells. Cancer Res 63:3860–3865
  PubMed Google Scholar
• Gouaze V, Liu YY, Prickett CS, Yu JY, Giuliano AE, Cabot MC (2005) Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res 65:3861–3867
  Article PubMed CAS Google Scholar
• Dijkhuis AJ, Klappe K, Jacobs S, Kroesen BJ, Kamps W, Sietsma H, Kok JW (2006) PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol Cancer Ther 5:593–601
  Article PubMed CAS Google Scholar
• Furlong SJ, Ridgway ND, Hoskin DW (2008) Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin. Int J Oncol 32:537–544
  PubMed CAS Google Scholar
• Kraveka JM, Li L, Szulc ZM, Bielawski J, Ogretmen B, Hannun YA, Obeid LM, Bielawska A (2007) Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem 282:16718–16728
  Article PubMed CAS Google Scholar
• Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, Mehendale H, Cabot MC, Li YT, Jazwinski SM (2010) Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Mol Cancer 9:145
  Article PubMed Google Scholar
• Rath G, Schneider C, Langlois B, Sartelet H, Morjani H, Btaouri HE, Dedieu S, Martiny L (2009) De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma. Int J Biochem Cell Biol 41:1165–1172
  Article PubMed CAS Google Scholar
• Liu YY, Patwardhan GA, Bhinge K, Gupta V, Gu X, Jazwinski SM (2011) Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Cancer Res 71:2276–2285
  Article PubMed CAS Google Scholar
• Cakir Z, Saydam G, Sahin F, Baran Y (2011) The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells. J Cancer Res Clin Oncol 137:279–286
  Article PubMed CAS Google Scholar
• Kartal M, Saydam G, Sahin F, Baran Y (2011) Resveratrol triggers apoptosis by increasing intracellular concentrations of ceramides in chronic myeloid leukemia cells. Nutrit Cancer An Internat J 63(4):637–644
  Article CAS Google Scholar
• Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B (2007) Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem 282:10922–10934
  Article PubMed CAS Google Scholar
• Camgoz A, Ural AU, Avcu F, Baran Y (2011) Targeting ceramide metabolism to increase intracellular concentrations of apoptotic ceramide increased cytotoxic effects of nilotinib in human chronic myeloid leukemia cells. Leuk and Lymph 52(8):1574–1584
  Article CAS Google Scholar
• Gencer AB, Ural AU, Avcu F, Baran Y (2011) Dasatinib induces apoptosis through increasing de novo generation or accumulation of ceramides in human K562 and Meg-01 chronic myeloid leukemia cells. Annals of Hemat 90(11):1265–1275
  Article CAS Google Scholar
• Bassoy EY, Baran Y (2012) Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells. Biomed Pharmacot 66(2):103–110
  Article CAS Google Scholar
• Olshefski RS, Ladisch S (2001) Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int J Cancer 93:131–138
  Article PubMed CAS Google Scholar
• Xie P, Shen YF, Shi YP, Ge SM, Gu ZH, Wang J, Mu HJ, Zhang B, Qiao WZ, Xie KM (2008) Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 32:475–480
  Article PubMed CAS Google Scholar